No Data
First Mpox Case Linked to African Outbreak Reported in U.K.
Bavarian Nordic Said to Have Won $63M Mpox Vaccine Contract From U.S.
U.S. to Donate 1M Mpox Shots to Address Outbreak in Africa: Report
Bavarian Nordic Receives EMA Approval Of Mpox Vaccine For Adolescents; Approval Extends Current Marketing Authorization To Include Adolescents 12 To 17 Years Of Age; Clinical Trial To Assess Immunogenicity, Safety Of MVA-BN In Children 2-12 Years Is...
Bavarian Nordic in Pact With Global Vaccine Group, Gavi for 500K Mpox Vaccines
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
No Data
No Data